Astin Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 19 Year, 7 Months
- Last Filing with ROC 31 Mar 2011
- Open Charges ₹ 3.30 Cr
About Astin Pharmaceuticals
Astin Pharmaceuticals Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 June 2005 and has a history of 19 years and seven months. Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2011. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.30 Cr.
Rifat Ali and Sambhu Singh serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74120DL2005PTC137306
-
Company No.
137306
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
07 Jun 2005
-
Date of AGM
30 Aug 2011
-
Date of Balance Sheet
31 Mar 2011
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Astin Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rifat Ali
|
Additional Director | 01-Jun-2013 | Current |
|
Sambhu Singh
|
Additional Director | 20-Feb-2013 | Current |
Financial Performance of Astin Pharmaceuticals.
Enhance accessibility to Astin Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Astin Pharmaceuticals?
Unlock access to Astin Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Krishna Medpharma Private LimitedRifat Ali and Sambhu Singh are mutual person
-
Sanador International Hospitality Private Limited
Rifat Ali and Sambhu Singh are mutual person
-
Luv Kush Medicare Private Limited
Rifat Ali and Sambhu Singh are mutual person
-
Rapid Continental Expo Private Limited
Sambhu Singh is a mutual person
Charges (Loans)
₹33.00 M
₹0
Charges Breakdown by Lending Institutions
- Punjab National Bank Jor Bagh : 3.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Sep 2011 | Punjab National Bank Jor Bagh | ₹3.30 Cr | Open |
How Many Employees Work at Astin Pharmaceuticals?
Unlock and access historical data on people associated with Astin Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Astin Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Astin Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
